Targeting histone deacetylases: development of vorinostat for the treatment of cancer
出版年份 2010 全文链接
标题
Targeting histone deacetylases: development of vorinostat for the treatment of cancer
作者
关键词
-
出版物
Epigenomics
Volume 2, Issue 3, Pages 457-465
出版商
Future Medicine Ltd
发表日期
2010-06-03
DOI
10.2217/epi.10.20
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A phase I/II study of vorinostat, an oral histone deacetylase inhibitor, in combination with azacitidine in patients with the myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Initial results of the phase I trial: A New York Cancer Consortium
- (2017) L. R. Silverman et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel Therapies in the Treatment of Multiple Myeloma
- (2017) Jacob P. Laubach et al. Journal of the National Comprehensive Cancer Network
- Modulation of thymidilate synthase and p53 expression by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with 5FU or Raltitrexed
- (2010) Elena Di Gennaro et al. CANCER BIOLOGY & THERAPY
- A phase I/II trial of vorinostat in combination with 5-fluorouracil in patients with metastatic colorectal cancer who previously failed 5-FU-based chemotherapy
- (2010) Peter M. Wilson et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
- (2010) Jiahuai Tan et al. Journal of Hematology & Oncology
- Histone Deacetylase Inhibitors in Malignant Pleural Mesothelioma: Preclinical Rationale and Clinical Trials
- (2010) Paul K. Paik et al. Journal of Thoracic Oncology
- Chemical phylogenetics of histone deacetylases
- (2010) James E Bradner et al. Nature Chemical Biology
- DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines
- (2009) Melissa J LaBonte et al. BMC Medical Genomics
- Development of vorinostat: Current applications and future perspectives for cancer therapy
- (2009) Victoria M. Richon et al. CANCER LETTERS
- Enhancing the apoptotic and therapeutic effects of HDAC inhibitors
- (2009) Ailsa J. Frew et al. CANCER LETTERS
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- (2009) Takashi Watanabe et al. CANCER SCIENCE
- Epigenetic Modifiers: Basic Understanding and Clinical Development
- (2009) R. L. Piekarz et al. CLINICAL CANCER RESEARCH
- A Phase I, Pharmacokinetic and Pharmacodynamic Study on Vorinostat in Combination with 5-Fluorouracil, Leucovorin, and Oxaliplatin in Patients with Refractory Colorectal Cancer
- (2009) M. G. Fakih et al. CLINICAL CANCER RESEARCH
- A Single Supratherapeutic Dose of Vorinostat Does Not Prolong the QTc Interval in Patients with Advanced Cancer
- (2009) P. N. Munster et al. CLINICAL CANCER RESEARCH
- Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma
- (2009) A. Badros et al. CLINICAL CANCER RESEARCH
- Rational Combinations Using HDAC Inhibitors
- (2009) M. Bots et al. CLINICAL CANCER RESEARCH
- Vorinostat enhances the antimyeloma effects of melphalan and bortezomib
- (2009) Richard A. Campbell et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cells
- (2009) William Fazzone et al. INTERNATIONAL JOURNAL OF CANCER
- Nonclinical Safety Assessment of the Histone Deacetylase Inhibitor Vorinostat
- (2009) Janet S. Kerr et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
- (2009) Evanthia Galanis et al. JOURNAL OF CLINICAL ONCOLOGY
- New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer
- (2009) Shundong Cang et al. Journal of Hematology & Oncology
- Vorinostat in solid and hematologic malignancies
- (2009) David Siegel et al. Journal of Hematology & Oncology
- Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
- (2009) C. Choudhary et al. SCIENCE
- Constitutive Activation of Signal Transducers and Activators of Transcription Predicts Vorinostat Resistance in Cutaneous T-Cell Lymphoma
- (2008) V. R. Fantin et al. CANCER RESEARCH
- An Inactivating Mutation in HDAC2 Leads to Dysregulation of Apoptosis Mediated by APAF1
- (2008) Christin L. Hanigan et al. GASTROENTEROLOGY
- Expression profile of histone deacetylases 1, 2 and 3 in ovarian cancer tissues
- (2008) Ke Long Jin et al. Journal of Gynecologic Oncology
- The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
- (2008) Xiang-Jiao Yang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Histone deacetylase 2 expression predicts poorer prognosis in oral cancer patients
- (2008) Hao-Hueng Chang et al. ORAL ONCOLOGY
- HDAC3 overexpression and colon cancer cell proliferation and differentiation
- (2007) Colleen C. Spurling et al. MOLECULAR CARCINOGENESIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now